Interstitial lung disease
hideInterstitial lung disease (ILD), also known as diffuse parenchymal lung disease (DPLD), refers to a group of lung diseases affecting the interstitium (the tissue and space around the air sacs of the lungs). It concerns alveolar epithelium, pulmonary capillary endothelium, basement membrane, perivascular and perilymphatic tissues.
The term ILD is used to distinguish these diseases from obstructive airways diseases.
Most types of ILD involve fibrosis, but this is not essential. The term "pulmonary fibrosis" is no longer considered a synonym. Idiopathic pulmonary fibrosis is one form of "interstitial lung disease".
For more information about Interstitial lung disease, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with pulmonary fibrosis
Still holding their breath: Mortality on lung transplant wait list remains high for some
Aug 24, 2009 |
not rated yet |
0
Mortality remains high among patients with pulmonary arterial hypertension awaiting lung transplant, despite changes to the allocation system that were designed to reduce mortality and increase the equitable distribution ...
Researchers discover therapeutic target that could help patients with pulmonary fibrosis
Aug 23, 2009 |
3 / 5 (1) |
0
A diagnosis of Idiopathic Pulmonary Fibrosis is not much better than a death sentence: there is no treatment and the survival rate is less than three years.
Placenta-derived stem cells may help sufferers of lung diseases
Jul 27, 2009 |
not rated yet |
0
An Italian research team, publishing in the current issue of Cell Transplantation (18:4), has found that stem cells derived from human placenta may ultimately play a role in the treatment of lung diseases, such as pulmon ...
Pitt team first to profile genes in acutely ill idiopathic pulmonary fibrosis patients
Jul 07, 2009 |
not rated yet |
0
The first findings from a one-of-a-kind, patient-driven effort to provide lung tissue for research might help doctors predict when patients with idiopathic pulmonary fibrosis (IPF) are becoming dangerously ill and also could ...
Protein may be strongest indicator of rare lung disease, study shows
Jun 04, 2009 |
not rated yet |
0
Researchers at the University of Cincinnati (UC) have discovered a protein in the lungs that can help in determining progression of the rare lung disease Idiopathic Pulmonary Fibrosis (IPF).
Large clinical trial finds pirfenidone may help lung function in IPF patients
May 17, 2009 |
5 / 5 (1) |
0
A large, well-controlled, multi-national clinical trial program has demonstrated the effectiveness and safety of what may become the first FDA-approved medicine for idiopathic pulmonary fibrosis, or IPF.
Note to people with scarred and stiffened lungs: Monitor your sleep before severe fatigue sets in
Jul 29, 2008 |
4.5 / 5 (2) |
0
Family, friends and neighbors remember Lisa Sandler Spaeth as an active mother of two in Potomac, Md., with a lot on the go, juggling her son's baseball games and her daughter's horseback-riding lessons with numerous committee ...
